Skip to main content

Table 3 Correlation of epicardial fat with markers for body composition and cardio-metabolic risks in patients with type 2 diabetes

From: Luseogliflozin reduces epicardial fat accumulation in patients with type 2 diabetes: a pilot study

  r p values
Body composition markers
 Body weight (kg) 0.310 0.196
 Body mass index (kg/m2) 0.485 0.044
 Waist circumference (cm) 0.364 0.126
 Visceral fat area (cm2) 0.467 0.044
 Subcutaneous fat area (cm2) 0.452 0.052
 Liver attenuation index −0.210 0.388
 Body fat (%) 0.249 0.304
 Total fat mass (kg) 0.484 0.036
 Total non-fat mass (kg) 0.103 0.675
 Skeletal muscle index 0.233 0.337
Cardio-metabolic markers
 HbA1c (%) −0.312 0.193
 HOMA-IR 0.502 0.046
 Triglycerides (mmol/l) −0.100 0.684
 HDL cholesterol (mmol/l) −0.041 0.869
 SBP (mmHg) 0.073 0.765
 DBP (mmHg) 0.309 0.198
 ALT (U/l) 0.175 0.475
 Log CRP (mg/l) 0.130 0.608
 Log ACR (mg/g) −0.143 0.561
 Adiponectin (μg/ml) 0.159 0.608
 Leptin (ng/ml) −0.143 0.561
 Log interleukin 6 (pg/ml) 0.174 0.490
  1. ACR albumin-to-creatinine ratio, ALT alanine transaminase, DBP diastolic blood pressure, HDL high-density lipoprotein, HOMA-IR homeostasis model assessment as an index of insulin resistance, SBP systolic blood pressure